
Pomerantz LLP has filed a class action lawsuit against Zoetis Inc. following the company's May 7, 2026, announcement of flat Q1 net income and a lowered full-year profit forecast. The stock price fell 21.5% after Zoetis cited a challenging environment with reduced veterinary visits and softer demand. Investors who bought Zoetis shares during the class period have until July 27, 2026, to join the lawsuit. The case alleges securities fraud or other unlawful business practices by Zoetis and its officers or directors.